P. Masciopinto

Diffuse Large B Cell Lymphoma Arising in Patients with Preexisting Hodgkin Lymphoma

G. Ingravallo, A. Guarini, E. Maiorano, 2022, Current Oncology.

The Role of Autoimmune Diseases in the Prognosis of Lymphoma

G. Dell'Olio, P. Musto, G. Specchia, 2020, Journal of clinical medicine.

Molecular Features and Diagnostic Challenges in Alpha/Beta T-Cell Large Granular Lymphocyte Leukemia

G. Ingravallo, E. Maiorano, P. Musto, 2022, International journal of molecular sciences.

Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes.

G. Ingravallo, E. Maiorano, P. Musto, 2022, Clinical lymphoma, myeloma & leukemia.

A real-world analysis of PD1 blockade from the Rete Ematologica Pugliese (REP) in patients with relapse/refractory Hodgkin’s lymphoma

V. Pavone, A. Guarini, G. Tarantini, 2023, Annals of Hematology.

In male Hodgkin lymphoma patients, impaired fertility may be improved by non‐gonadotoxic therapy

E. Cicinelli, P. Musto, G. Specchia, 2021, British journal of haematology.

The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy

D. Ribatti, G. Ingravallo, R. Tamma, 2023, Cancers.

Prognostic Role of CDKN2A Deletion and p53 Expression and Association With MIPIb in Mantle Cell Lymphoma.

G. Ingravallo, E. Maiorano, P. Musto, 2023, Clinical lymphoma, myeloma & leukemia.